{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:11:43Z","timestamp":1793398303419,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40120-021-00305-9","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:02:46Z","timestamp":1638565366000},"page":"205-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study"],"prefix":"10.1007","volume":"11","author":[{"given":"Yasuhiko","family":"Matsumori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1967-9829","authenticated-orcid":false,"given":"Kaname","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5134-037X","authenticated-orcid":false,"given":"Dena H.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"issue":"1","key":"305_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z. on behalf of Lifting The Burden: the Global Campaign against Headache. Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137.","journal-title":"J Headache Pain."},{"issue":"6","key":"305_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1046\/j.1468-2982.2003.00543.x","volume":"23","author":"RB Lipton","year":"2003","unstructured":"Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia. 2003;23(6):429\u201340.","journal-title":"Cephalalgia"},{"issue":"3","key":"305_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0333102410381145","volume":"31","author":"AM Blumenfeld","year":"2011","unstructured":"Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301\u201315.","journal-title":"Cephalalgia"},{"issue":"1","key":"305_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10194-021-01265-z","volume":"22","author":"TJ Steiner","year":"2021","unstructured":"Steiner TJ, Jensen R, Katsarava Z, et al. Structured Q1 headache services as the solution to the ill-health burden of headache: 1. Rationale and description. J Headache Pain. 2021;22(1):78.","journal-title":"J Headache Pain"},{"issue":"1","key":"305_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1468-2982.1997.1701015.x","volume":"17","author":"F Sakai","year":"1997","unstructured":"Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia. 1997;17(1):15\u201322.","journal-title":"Cephalalgia"},{"issue":"1","key":"305_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1526-4610.2004.04004.x","volume":"44","author":"T Takeshima","year":"2004","unstructured":"Takeshima T, Ishizaki K, Fukuhara Y, et al. Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache. 2004;44(1):8\u201319.","journal-title":"Headache"},{"issue":"11","key":"305_CR7","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1080\/03007995.2021.1971179","volume":"37","author":"K Hirata","year":"2021","unstructured":"Hirata K, Ueda K, Komori M, et al. Comprehensive population-based survey of migraine in Japan: results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Curr Med Res Opin. 2021;37(11):1945\u201355.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"305_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s10194-019-1062-4","volume":"20","author":"T Takeshima","year":"2019","unstructured":"Takeshima T, Wan Q, Zhang Y, et al. Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature. J Headache Pain. 2019;20(1):111.","journal-title":"J Headache Pain"},{"issue":"1","key":"305_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10194-021-01243-5","volume":"22","author":"T Shimizu","year":"2021","unstructured":"Shimizu T, Sakai F, Miyake H, et al. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain. 2021;22(1):29.","journal-title":"J Headache Pain"},{"issue":"1","key":"305_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s10194-021-01310-x","volume":"22","author":"M Tinelli","year":"2021","unstructured":"Tinelli M, Leonardi M, Paemeleire K, Mitsikostas D, de la Torre ER, Steiner TJ. Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology. J Headache Pain. 2021;22(1):99.","journal-title":"J Headache Pain"},{"issue":"1","key":"305_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-021-01305-8","volume":"22","author":"M Tinelli","year":"2021","unstructured":"Tinelli M, Leonardi M, Paemeleire K, et al. Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusions. J Headache Pain. 2021;22(1):90.","journal-title":"J Headache Pain"},{"issue":"11","key":"305_CR12","doi-asserted-by":"publisher","first-page":"e038987","DOI":"10.1136\/bmjopen-2020-038987","volume":"10","author":"H Igarashi","year":"2020","unstructured":"Igarashi H, Ueda K, Jung S, Cai Z, Chen Y, Nakamura T. Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey. BMJ Open. 2020;10(11):e038987.","journal-title":"BMJ Open"},{"issue":"1","key":"305_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s10194-020-01180-9","volume":"21","author":"S Kikui","year":"2020","unstructured":"Kikui S, Chen Y, Todaka H, Asao K, Adachi K, Takeshima T. Burden of migraine among Japanese patients: a cross-sectional National Health and Wellness Survey. J Headache Pain. 2020;21(1):110.","journal-title":"J Headache Pain"},{"issue":"S1","key":"305_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1526-4610.1994.hed34s1002.x","volume":"59","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Araujo AB, Nicholson RA, et al. Patterns of diagnosis, consultation, and treatment of migraine in the US: results of the OVERCOME study. Headache. 2019;59(S1):2\u20133.","journal-title":"Headache"},{"issue":"1","key":"305_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edn. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"issue":"7","key":"305_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646\u201357.","journal-title":"Headache"},{"issue":"3","key":"305_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1468-2982.2006.01275.x","volume":"27","author":"S Silberstein","year":"2007","unstructured":"Silberstein S, Loder E, Diamond S, Reed ML, Bigal ME, Lipton RB. Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia. 2007;27(3):220\u20139.","journal-title":"Cephalalgia"},{"issue":"6 Suppl 1","key":"305_CR18","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1212\/WNL.56.suppl_1.S20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20\u20138.","journal-title":"Neurology"},{"issue":"2","key":"305_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1468-2982.1999.019002107.x","volume":"19","author":"WF Stewart","year":"1999","unstructured":"Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999;19(2):107\u201314.","journal-title":"Cephalalgia"},{"issue":"4","key":"305_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1526-4610.2003.03069.x","volume":"43","author":"M Iigaya","year":"2003","unstructured":"Iigaya M, Sakai F, Kolodner KB, Lipton RB, Stewart WF. Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire. Headache. 2003;43(4):343\u201352.","journal-title":"Headache"},{"issue":"3","key":"305_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1046\/j.1526-4610.2000.00030.x","volume":"40","author":"BC Martin","year":"2000","unstructured":"Martin BC, Pathak DS, Sharfman MI, et al. Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache. 2000;40(3):204\u201315.","journal-title":"Headache"},{"issue":"6","key":"305_CR22","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2165\/00019053-199813060-00007","volume":"13","author":"P Jhingran","year":"1998","unstructured":"Jhingran P, Davis SM, LaVange LM, Miller DW, Helms RW. MSQ: Migraine-Specific Quality-of-Life Questionnaire. Further investigation of the factor structure. Pharmacoeconomics. 1998;13(6):707\u201317.","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"305_CR23","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1468-2982.2009.01852.x","volume":"29","author":"JC Cole","year":"2009","unstructured":"Cole JC, Lin P, Rupnow MFT. Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version. Cephalalgia. 2009;29(11):1180\u20137.","journal-title":"Cephalalgia"},{"issue":"8","key":"305_CR24","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1023\/B:QURE.0000040787.20364.89","volume":"13","author":"S Ohbu","year":"2004","unstructured":"Ohbu S, Igarashi H, Okayasu H, et al. Development and testing of the Japanese version of the Migraine-Specific Quality of Life instrument. Qual Life Res. 2004;13(8):1489\u201393.","journal-title":"Qual Life Res"},{"key":"305_CR25","first-page":"449","volume":"21","author":"F Sakai","year":"2004","unstructured":"Sakai F, Fukuuchi Y, Iwata M, et al. Reliability and validity of the Japanese version of the migraine quality of life survey [in Japanese]. Neurol Therapeutics [Japan]. 2004;21:449\u201358.","journal-title":"Neurol Therapeutics [Japan]"},{"key":"305_CR26","first-page":"A89","volume":"68","author":"DC Buse","year":"2007","unstructured":"Buse DC, Bigal MB, Rupnow M, Reed M, Serrano D, Lipton R. Development and validation of the Migraine Interictal Burden Scale (MIBS): a self-administered instrument for measuring the burden of migraine between attacks. Neurology. 2007;68:A89.","journal-title":"Neurology"},{"issue":"5","key":"305_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0025-6196(11)60561-2","volume":"84","author":"DC Buse","year":"2009","unstructured":"Buse DC, Rupnow MFT, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84(5):422\u201335.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"305_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353\u201365.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"305_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s10194-019-1012-1","volume":"20","author":"K Ueda","year":"2019","unstructured":"Ueda K, Ye W, Lombard L, et al. Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme. J Headache Pain. 2019;20(1):68.","journal-title":"J Headache Pain"},{"key":"305_CR30","first-page":"1","volume":"3","author":"F Sakai","year":"2020","unstructured":"Sakai F, Ozeki A, Skljarevski V. Efficacy and safety of galcanezumab for prevention of migraine headache in Japanese patients with episodic migraine: a phase 2 randomized controlled clinical trial. Cephalalgia Rep. 2020;3:1\u201310.","journal-title":"Cephalalgia Rep"},{"key":"305_CR31","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.2147\/JPR.S287781","volume":"13","author":"M Shibata","year":"2020","unstructured":"Shibata M, Nakamura T, Ozeki A, Ueda K, Nichols RM. Migraine-Specific Quality-of-Life Questionnaire (MSQ) version 2.1 score improvement in Japanese patients with episodic migraine by galcanezumab treatment: Japan Phase 2 study. J Pain Res. 2020;13:3531\u20138.","journal-title":"J Pain Res"},{"issue":"10","key":"305_CR32","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1177\/0333102420921162","volume":"40","author":"DW Dodick","year":"2020","unstructured":"Dodick DW, Ashina M, Sakai F, et al. Vancouver Declaration II on Global Headache Patient Advocacy 2019. Cephalalgia. 2020;40(10):1017\u201325.","journal-title":"Cephalalgia."},{"issue":"Suppl 1","key":"305_CR33","first-page":"384","volume":"39","author":"L Schaetz","year":"2019","unstructured":"Schaetz L, Rimner T, Pathak P, Fang J, Chandrasekhar D, Mueller J. Impact of an employer-provided migraine coaching program on burden and patient engagement: results from interim analysis [abstract]. Cephalalgia. 2019;39(Suppl 1):384\u20135.","journal-title":"Cephalalgia"},{"key":"305_CR34","unstructured":"Gallup. Wellcome Global Monitor\u2014First Wave Findings. 2019. https:\/\/wellcome.org\/reports\/wellcome-global-monitor\/2018. Accessed 26 Jun 2021."},{"issue":"2","key":"305_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00776-013-0525-8","volume":"19","author":"M Nakamura","year":"2014","unstructured":"Nakamura M, Toyama Y, Nishiwaki Y, Ushida T. Prevalence and characteristics of chronic musculoskeletal pain in Japan: a second survey of people with or without chronic pain. J Orthop Sci. 2014;19(2):339\u201350.","journal-title":"J Orthop Sci"},{"issue":"12","key":"305_CR36","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1177\/0333102419851855","volume":"39","author":"JL Meyers","year":"2019","unstructured":"Meyers JL, Davis KL, Lenz RA, Sakai F, Xue F. Treatment patterns and characteristics of patients with migraine in Japan: a retrospective analysis of health insurance claims data. Cephalalgia. 2019;39(12):1518\u201334.","journal-title":"Cephalalgia"},{"issue":"5","key":"305_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343\u20139.","journal-title":"Neurology"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-021-00305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-021-00305-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-021-00305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T16:23:36Z","timestamp":1645201416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-021-00305-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1007\/s40120-021-00305-9","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,3]]},"assertion":[{"value":"1 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}